Biotricity Inc.
BTCY- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001630113
No open-market purchases or sales by Biotricity Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $5.99K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Biotricity Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 23 | 22 | −1 |
| SharesConverted for a 1-for-6 split | 484.5K | 506.5K | +22.0K (+4.5%) |
| Value | $1.85M | $1.08M | −$773.8K (−41.8%) |
New holders (5)
Institutions that held Biotricity Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 30,533 | $63.8K | 0.00% |
| Cedar Mountain Advisors, LLC | 2,501 | $5.35K | 0.00% |
| Royal Bank of Canada | 640 | $1.00K | 0.00% |
| Morgan Stanley | 71 | $152 | 0.00% |
| JPMorgan Chase & Co | 8 | $17 | 0.00% |
Sold out (6)
Institutions that held Biotricity Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Signature Wealth Management Partners, LLC | 37,798 | $24.1K |
| Charles Schwab Investment Management Inc | 16,000 | $10.2K |
| Jane Street Group, LLC | 10,235 | $6.53K |
| Moors & Cabot, Inc. | 10,000 | $6.38K |
| Schechter Investment Advisors, LLC | 10,000 | $6.38K |
| Citadel Advisors LLC | 63 | $40 |